Skip to main content
. 2019 May 14;6(3):339–352. doi: 10.1007/s40744-019-0157-3

Table 4.

Patients with lack or loss of efficacy by ADA status

No. of patients (%) ADA negative (n = 103) ADA positive (n = 28)
Lack of efficacy 1 (1.0) 1 (3.6)
 Permanent treatment discontinuation due to lack of efficacy 1 (1.0) 1 (3.6)
Loss of efficacy 0 0

ADA antidrug antibody